MDGL

Madrigal Pharmaceuticals Inc

MDGL.US madrigalpharma.com + Research + Basket
CIK 0001157601
Employees 915
Phone 267 824 2827
Fiscal year end December
IPO Feb 06, 2007
Address 1001 Conshohocken State Road, West Conshohocken, PA, United States, 19428
431.70
+0.70 (+0.16%)
USD · NASDAQ
52-week range
399.00
615.00
Trading at 15% of the 52-week range
Market Cap
9.96B
P/E Ratio
0.00
Forward P/E
67.11
Book Value
22.68
Div. Yield
N/A
% Institutions
104.44%
% Insiders
5.83%

1 Year

+2.4%

3 Year

+242.2%

10 Year

+2,516.4%
Description

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.

Actions

Add an action for MDGL.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Mr. William J. Sibold CEO, President & Director 1966
Dr. Rebecca A. Taub M.D. Founder, Senior Scientific & Medical Advisor and Director 1952
Ms. Mardi C. Dier Executive VP & CFO 1964
Ms. Shannon Kelley Executive VP, Chief Legal Officer & Corporate Secretary 1975
Ms. Carole Huntsman Executive VP & Chief Commercial Officer 1965
Dr. David Soergel M.D. Executive VP & Chief Medical Officer 1968
Mr. Mark Underwood Executive Vice President of Business Planning & Operations NA
Ms. Rita Thakkar Senior VP & Chief Accounting Officer 1974
Mr. Ronald Filippo Executive VP & Chief Information Officer NA
Ms. Tina E. Ventura Chief Investor Relations Officer NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Mar 06, 2026 Mardi Dier N/A Sale 1.98K $430.87 $853.98K SEC
Mar 06, 2026 Carole Huntsman N/A Sale 419.00 $431.94 $180.98K SEC
Mar 06, 2026 William John Sibold N/A Sale 1.66K $431.94 $718.32K SEC
Mar 06, 2026 Rebecca Taub N/A Sale 491.00 $431.94 $212.08K SEC
Mar 06, 2026 Shannon T Kelley N/A Sale 360.00 $431.94 $155.50K SEC
Mar 02, 2026 Mardi Dier N/A Sale 1.18K $427.21 $505.39K SEC
Jan 26, 2026 Carole Huntsman N/A Sale 910.00 $493.78 $449.34K SEC
Jan 26, 2026 Rebecca Taub N/A Sale 647.00 $492.42 $318.60K SEC
Jan 26, 2026 William John Sibold N/A Sale 1.58K $492.42 $776.55K SEC
Jan 20, 2026 Rebecca Taub N/A Sale 2.24K $490.77 $1.10M SEC
Jan 20, 2026 Shannon T Kelley N/A Sale 692.00 $497.36 $344.17K SEC
Jan 09, 2026 Paul A Friedman N/A Sale 24.52K $522.39 $12.81M SEC
Jan 09, 2026 Rebecca Taub N/A Sale 18.41K $522.40 $9.62M SEC
Jan 09, 2026 Rebecca Taub N/A Sale 240.00 $550.33 $132.08K SEC
Jan 09, 2026 Paul A Friedman N/A Sale 280.00 $551.24 $154.35K SEC
Dec 10, 2025 Paul A Friedman N/A Sale 24.80K $552.18 $13.69M SEC
Dec 10, 2025 Rebecca Taub N/A Sale 18.65K $552.15 $10.30M SEC
Dec 04, 2025 William John Sibold N/A Sale 2.40K $575.34 $1.38M SEC
Dec 02, 2025 Mardi Dier N/A Sale 4.17K $578.34 $2.41M SEC
Nov 21, 2025 Carole Huntsman N/A Sale 1.96K $553.11 $1.08M SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Baker Bros Advisors LP 2.14M Jun 30, 2026 9.28% $5.77 0.07%
HHG PLC 2.02M Mar 31, 2026 8.74% $0.50 27.37%
RTW INVESTMENTS, LLC 1.99M Jun 30, 2026 8.63% $9.14 0.00%
Jupiter Topco LLC 1.94M Jun 30, 2026 8.38% $0.42 0.00%
venBio Select Advisor LLC 1.83M Jun 30, 2026 7.94% $8.84 0.83%
Paulson & Company Inc 1.34M Jun 30, 2026 5.80% $27.94 -3.75%
BlackRock Inc 1.20M Jun 30, 2026 5.20% $0.01 -23.03%
Vanguard Capital Management, LLC 835.67K Jun 30, 2026 3.62% $0.01 1.03%
Wellington Management Company LLP 825.71K Jun 30, 2026 3.57% $0.08 18.81%
Vanguard Portfolio Management, LLC 781.73K Jun 30, 2026 3.38% $0.02 -7.06%
State Street Corp 527.06K Jun 30, 2026 2.28% $0.01 -13.53%
Citadel Advisors Llc 507.23K Jun 30, 2026 2.20% $0.03 11.76%
UBS Group AG 401.71K Jun 30, 2026 1.74% $0.03 241.07%
Geode Capital Management, LLC 374.88K Jun 30, 2026 1.62% $0.01 -17.77%
FMR Inc 356.20K Jun 30, 2026 1.54% $0.01 -30.39%
William Blair Investment Management, LLC 324.12K Jun 30, 2026 1.40% $0.52 -4.82%
Amvescap Plc. 301.44K Jun 30, 2026 1.30% $0.01 -8.52%
Armistice Capital, LLC 288.00K Jun 30, 2026 1.25% $1.89 8.85%
Lord, Abbett & Co LLC 281.50K Jun 30, 2026 1.22% $0.43 15.97%
Assenagon Asset Management SA 248.43K Jun 30, 2026 1.08% $0.08 1,449.48%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard MStar Total Stk Mkt Idx Invest 587.78K 2.54% ▲ 0.27% Sep 30, 2026
2 Vanguard Health Care Inv 521.93K 2.26% ▲ 17.51% Jun 30, 2026
3 Vanguard Small Cap Index 416.15K 1.80% ▼ 1.96% Sep 30, 2026
4 Polar Capital Biotech S Inc 349.55K 1.51% ▲ 27.58% Aug 31, 2026
5 Janus Henderson Forty S 338.60K 1.47% ▲ 0.00% Aug 31, 2026
6 State Street® SPDR® S&P® Biotech ETF 272.06K 1.18% ▼ 1.88% Sep 30, 2026
7 Janus Henderson Enterprise D 233.27K 1.01% ▲ 0.00% Aug 31, 2026
8 Vanguard MStar Small Cap Growth Indx Inv 231.70K 1.00% ▼ 4.88% Sep 30, 2026
9 Vanguard Explorer Inv 182.64K 0.79% ▲ 310.96% Jun 30, 2026
10 First Trust NYSE Arca Biotech ETF 168.69K 0.73% ▲ 0.00% Sep 30, 2026

Financial Highlights

▼
Market Cap: $9.96B
EBITDA: $-321.10M
PEG Ratio: $0.00
Book Value: $22.68
Earnings/Share: $-12.85
Profit Margin: -25.32%
Operating Margin: -15.46%
ROA (TTM): -17.84%
ROE (TTM): -53.31%
Revenue (TTM): $1.28B
Revenue/Share (TTM): $56.15
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 71.20%

Valuation Metrics

Enterprise Value: $9.47B
Trailing P/E: 0.00
Forward P/E: 67.11

Shares Statistics

Shares Outstanding: 23.10M
Shares Float: 13.72M
% Insiders: 5.83%
% Institutions: 104.44%
Shares Short: 2.19M
Shares Short (Prior Month): 2.40M
Short Ratio: 7.90
Short % Float: 11.17%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$958.40M
Cost of Goods Sold
adjust
$-56.15M
Gross Profit
subtotal
$902.26M
SG&A
adjust
$-813.83M
R&D
adjust
$-388.53M
Operating Income
subtotal
$-300.10M
Other / Non-Operating Items
adjust
$11.81M
Net Income
subtotal
$-288.28M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about MDGL.US!